News

Novo Nordisk: Enough Is Enough
Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...
Faux-zempic danger: How to tell if YOUR jab is a convincing fake - as TV star reveals near death experience after 'horror' injection
Health officials have issued yet another warning over the perils of fake weight loss jabs after an influencer nearly died ...
Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...